Gene · 7079
Papers1,944
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,944
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting interleukin-21 inhibits stress overload-induced cardiac remodelling via the TIMP4/MMP9 signalling pathway. | Eur J Pharmacol | 2023 | 36587888 | PubTator, text mining | PubMed |
| COVID-19 plasma proteome reveals novel temporal and cell-specific signatures for disease severity and high-precision disease management. | J Cell Mol Med | 2023 | 36537107 | PubTator, text mining | PubMed |
| ADAM10 mediates shedding of carbonic anhydrase IX ectodomain non‑redundantly to ADAM17. | Oncol Rep | 2023 | 36524367 | PubTator, text mining | PubMed |
| Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics. | Semin Cancer Biol | 2023 | 36521737 | PubTator, text mining | PubMed |
| Scar-Degrading Endothelial Cells as a Treatment for Advanced Liver Fibrosis. | Adv Sci (Weinh) | 2023 | 36494102 | PubTator, text mining | PubMed |
| Tissue inhibitor of metalloproteinase-4 deletion in mice impacts maternal cardiac function during pregnancy and postpartum. | Am J Physiol Heart Circ Physiol | 2023 | 36459450 | PubTator, text mining | PubMed |
| Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support. | Circulation | 2023 | 36448446 | PubTator, text mining | PubMed |
| Circulating levels of tissue inhibitor of metalloproteinase 3, a protein with inhibitory effects on angiogenesis, are increased in pre-eclampsia. | Int J Gynaecol Obstet | 2023 | 36333976 | PubTator, text mining | PubMed |
| Circulating Proteins Influencing Psychiatric Disease: A Mendelian Randomization Study. | Biol Psychiatry | 2023 | 36280454 | PubTator, text mining | PubMed |
| Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women. | Diabetologia | 2023 | 36114877 | PubTator, text mining | PubMed |
| Cellular-scale sex differences in extracellular matrix remodeling by valvular interstitial cells. | Heart Vessels | 2023 | 36070095 | PubTator, text mining | PubMed |
| Metabolic and molecular responses of human patellar tendon to concentric- and eccentric-type exercise in youth and older age. | Geroscience | 2023 | 35948859 | PubTator, text mining | PubMed |
| Matrix metalloproteinase-induced cervical extracellular matrix remodelling in pregnancy and cervical cancer. | Reprod Fertil | 2022 | 37931406 | PubTator, text mining | PubMed |
| Kisspeptin Is Upregulated at the Maternal-Fetal Interface of the Preeclamptic-like BPH/5 Mouse and Normalized after Synchronization of Sex Steroid Hormones. | Reprod Med (Basel) | 2022 | 37538930 | PubTator, text mining | PubMed |
| A seven-gene prognosis model to predict biochemical recurrence for prostate cancer based on the TCGA database. | Front Surg | 2022 | 37255653 | PubTator, text mining | PubMed |
| Placental macrophages present distinct polarization pattern and effector functions depending on clinical onset of preeclampsia. | Front Immunol | 2022 | 36713449 | PubTator, text mining | PubMed |
| Insights into the immunomodulatory regulation of matrix metalloproteinase at the maternal-fetal interface during early pregnancy and pregnancy-related diseases. | Front Immunol | 2022 | 36700222 | PubTator, text mining | PubMed |
| Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game? | Front Mol Biosci | 2022 | 36699696 | PubTator, text mining | PubMed |
| Urinary Exosomal Tissue TIMP and Angiopoietin-1 Are Preoperative Novel Biomarkers of Well-Differentiated Thyroid Cancer. | Biomedicines | 2022 | 36672532 | PubTator, text mining | PubMed |
| Preventive and therapeutic effects of green tea on lung cancer: a narrative review of evidence from clinical and basic research. | J Thorac Dis | 2022 | 36647481 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7079/papers?page=13